Analysts Have Just Cut Their Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Revenue Estimates By 13% [Yahoo! Finance]
Ironwood Pharmaceuticals, Inc. - Class A (IRWD)
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ironwoodpharma.com
Company Research
Source: Yahoo! Finance
NASDAQ:IRWD ), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a little shell-shocked. Revenue estimates were cut sharply as the analysts signalled a weaker outlook - perhaps a sign that investors should temper their expectations as well. Following the latest downgrade, the six analysts covering Ironwood Pharmaceuticals provided consensus estimates of US$356m revenue in 2024, which would reflect a not inconsiderable 11% decline on its sales over the past 12 months. Before the latest update, the analysts were foreseeing US$410m of revenue in 2024. The consensus view seems to have become more pessimistic on Ironwood Pharmaceuticals, noting the measurable cut to revenue estimates in this update. Check out our latest analysis for Ironwood Pharmaceuticals The consensus price target fell 21% to US$12.50, with the analysts clearly less optimistic about Ironwood Pharmaceuticals' valuation following this update. Looking at the b
Show less
Read more
Impact Snapshot
Event Time:
IRWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRWD alerts
High impacting Ironwood Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
IRWD
News
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was upgraded by analysts at Leerink Partnrs to a "hold" rating.MarketBeat
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $5.00 price target on the stock.MarketBeat
- Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare ConferenceBusiness Wire
- Ironwood Pharmaceuticals, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts [Yahoo! Finance]Yahoo! Finance
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) had its price target lowered by analysts at Wells Fargo & Company from $14.00 to $12.00. They now have an "overweight" rating on the stock.MarketBeat
IRWD
Earnings
- 8/8/24 - Miss
IRWD
Sec Filings
- 9/18/24 - Form 4
- 8/14/24 - Form 4
- 8/14/24 - Form 4
- IRWD's page on the SEC website